Generic Name : Imatinib
Brand Name : Imatib
Manufacturer Name : Cipla India
Product Code : OBP 562
Delivery Days : 10 To 12 Working Days
Composition : Imatinib
Strength : 400mg
Packaging : Tablet (Blisters)
Presentation : Pills Strip
Drug Class : Kinase inhibitors
Prescribed For : Treat certain types of leukemia (cancer that begins in the white blood cells) and other cancers and disorders of the blood cells
Side Effects : Abdominal or stomach pain, cramping, burning, or tenderness, bleeding problems, bloating or swelling of the face, hands, lower legs, or feet, blood in the urine, bloody eye
| Pack Size/Qty | Price | Price Per Pill or unit | |
| 90 TABLET'S | $461.70 | $5.13 | |
| 60 TABLET'S | $308.40 | $5.14 | |
| 30 TABLET'S | $154.50 | $5.15 |
Imatib 400 MG Capsule is a medication used in the treatment of certain types of cancers. The active ingredient in Imatib 400 MG Capsule is imatinib mesylate, which belongs to a class of drugs known as tyrosine kinase inhibitors. This medication is primarily prescribed for its ability to inhibit the activity of specific proteins involved in the abnormal growth and division of cancer cells.
Here's a breakdown of how Imatib 400 MG Capsule works:
Inhibition of Tyrosine Kinases: Imatib is classified as a tyrosine kinase inhibitor. It specifically targets and inhibits tyrosine kinases, particularly those associated with specific proteins like BCR-ABL, KIT, and PDGFRA. These proteins are often overactive or mutated in cancer cells.
BCR-ABL Inhibition (Chronic Myeloid Leukemia - CML): In conditions like Chronic Myeloid Leukemia (CML), Imatib targets and inhibits the BCR-ABL fusion protein, which is characteristic of CML cells. By inhibiting this abnormal protein, Imatib disrupts the signaling pathways that drive the uncontrolled growth of leukemia cells.
KIT and PDGFRA Inhibition (Gastrointestinal Stromal Tumors - GIST): In the case of Gastrointestinal Stromal Tumors (GIST), Imatib targets and inhibits the activity of tyrosine kinases associated with the KIT protein and PDGFRA. Mutations in these proteins are common in GIST, and by inhibiting them, Imatib helps to slow down the growth of these tumors.
Disruption of Cancer Cell Signaling: By inhibiting tyrosine kinases, Imatib interferes with the signaling cascades that promote the survival, growth, and division of cancer cells. This disruption helps to reduce the proliferation of cancerous cells.
Ingredients:
The active ingredient in Imatib 400 MG Capsule is imatinib mesylate. Each capsule contains 400 milligrams of imatinib mesylate. Imatinib mesylate belongs to the class of drugs known as tyrosine kinase inhibitors.
Dosage:
The dosage of Imatib 400 MG Capsule is determined by healthcare professionals based on the specific type of cancer being treated, the stage of the disease, and individual patient factors. It is crucial for patients to follow the prescribed dosage and administration schedule for optimal treatment outcomes.
It's important to note that the dosing schedule may also vary depending on the indication. Imatib is typically taken orally, with or without food, as directed by the healthcare provider.
Imatib 400 MG Capsule is typically prescribed for individuals diagnosed with certain types of cancers that are responsive to its mechanism of action. The decision to use Imatib 400 MG Capsule is made by healthcare professionals based on a thorough assessment of the patient's medical condition, including the specific type and stage of cancer. It is commonly prescribed for the treatment of:
Chronic Myeloid Leukemia (CML): Imatib is often used for individuals diagnosed with Chronic Myeloid Leukemia, a type of cancer that affects the blood and bone marrow.
Acute Lymphoblastic Leukemia (ALL): In certain cases, Imatib may be prescribed for the treatment of Acute Lymphoblastic Leukemia, a fast-growing cancer of the white blood cells.
Gastrointestinal Stromal Tumors (GIST): Imatib is effective in the treatment of Gastrointestinal Stromal Tumors, which are tumors that occur in the gastrointestinal tract, often in the stomach or small intestine.
Dermatofibrosarcoma Protuberans (DFSP): Imatib may also be used for the treatment of Dermatofibrosarcoma Protuberans, a rare form of skin cancer.
Avoiding common mistakes is crucial to ensure the safe and effective use of Imatib 400 MG Capsule. Here are key points to avoid:
Self-Adjusting Dosage:
Patients should never self-adjust the dosage of Imatib. Any changes to the prescribed dosage should be made under the guidance of a healthcare professional.
Skipping Regular Check-ups:
Regular medical check-ups are vital to monitor the medication's effectiveness and manage potential side effects. Skipping these appointments can compromise the quality of care.
Not Reporting Side Effects Promptly:
Patients should promptly report any side effects or changes in health to their healthcare provider. Open communication helps in timely intervention and management of potential issues.
Inconsistent Medication Schedule:
Consistency in taking Imatib is crucial. Patients should take the medication at the same time each day and follow their healthcare provider's instructions regarding food intake.
Not Informing About Pregnancy or Breastfeeding:
If there is a chance of pregnancy or if the patient is breastfeeding, it's important to inform the healthcare provider. Imatib may have potential risks during pregnancy, and alternative plans may need to be discussed.
Not Following Dietary Recommendations:
Some dietary restrictions may apply during Imatib treatment. Patients should follow any dietary recommendations provided by their healthcare provider to optimize the medication's effects.
Missing Doses Without Consultation:
If a dose is missed, patients should contact their healthcare provider for guidance on how to proceed. It is not advisable to double up on doses without consulting a healthcare professional.
Not Disclosing Full Medical History:
Patients should provide a comprehensive medical history, including any allergies, existing medical conditions, and other medications or supplements being taken. This information is crucial for safe prescribing.
Ignoring Severe Side Effects:
In case of severe side effects such as difficulty breathing, severe skin reactions, or signs of infection, patients should seek immediate medical attention. Ignoring serious side effects can have serious consequences.
Not Seeking Clarification:
Patients should seek clarification from their healthcare provider about any doubts or concerns related to the use of Imatib. It's important to have a clear understanding of the treatment plan.
Online Blue Pills is a leading online pharmacy for all your medical needs. If you want to shop Imatib 400 MG Capsule online in the USA, Online Blue Pills is your go-to destination. Get medicines at the most affordable prices and quickly delivered across the USA only from Online Blue Pills.
Q: What is Imatib 400 MG Capsule used for?
A: Imatib 400 MG Capsule is used in the treatment of certain types of cancers, including Chronic Myeloid Leukemia (CML), Acute Lymphoblastic Leukemia (ALL), Gastrointestinal Stromal Tumors (GIST), and Dermatofibrosarcoma Protuberans (DFSP).
Q: How does Imatib 400 MG Capsule work?
A: Imatib works by inhibiting the activity of specific proteins called tyrosine kinases. By blocking these proteins, it interferes with the abnormal growth and division of cancer cells.
Q: What is the recommended dosage of Imatib 400 MG Capsule?
A: The recommended dosage is determined by the healthcare provider based on the type of cancer being treated and individual patient factors. Adherence to the prescribed dosage and schedule is crucial for optimal treatment outcomes.
Q: How should I take Imatib 400 MG Capsule?
A: Imatib is usually taken orally with a glass of water. It can be taken with or without food, but consistency in administration is important. Follow the specific instructions provided by your healthcare provider.
Q: What should I do if I miss a dose of Imatib 400 MG Capsule?
A: If a dose is missed, contact your healthcare provider for guidance on how to proceed. It is not advisable to double up on doses without consulting a healthcare professional.
Q: What are the common side effects of Imatib 400 MG Capsule?
A: Common side effects may include nausea, vomiting, edema (swelling), fatigue, muscle cramps, and changes in skin texture. Report any severe or persistent side effects to your healthcare provider.
Q: Can I consume alcohol while using Imatib 400 MG Capsule?
A: Consult with your healthcare provider regarding alcohol consumption, as interactions between Imatib and alcohol may exist. Disclose your alcohol consumption habits to your healthcare professional.
Q: Can pregnant or breastfeeding individuals use Imatib 400 MG Capsule?
A: Pregnant or breastfeeding individuals should discuss their condition with their healthcare provider. Imatib may have potential risks during pregnancy, and alternative plans may need to be considered.
Q: How often should I have medical check-ups while using Imatib 400 MG Capsule?
A: Regular medical check-ups are essential to monitor the medication's effectiveness and manage potential side effects. The frequency of check-ups will be determined by your healthcare provider.
Q: Can I continue using other medications while on Imatib 400 MG Capsule?
A: Inform your healthcare provider about all medications, including over-the-counter drugs and
supplements, to avoid potential interactions. Adjustments to other medications may be necessary during Imatib treatment.
Common side effects of Imatib may include:
Nausea: Feeling queasy or having an urge to vomit is a common side effect of Imatib.
Vomiting: Some individuals may experience episodes of vomiting while taking Imatib.
Edema (Swelling): Imatib may lead to fluid retention, causing swelling in different parts of the body, such as the legs or ankles.
Muscle Cramps: Some people may experience cramping or muscle pain as a side effect of Imatib.
Fatigue: Feeling tired or experiencing a lack of energy is a common side effect.
Diarrhea: Imatib can cause changes in bowel habits, leading to diarrhea.
Rash or Skin Reactions: Some individuals may develop a rash or experience changes in skin texture.
Abdominal Pain: Pain or discomfort in the abdominal area is a reported side effect.
Headache: Imatib use may be associated with headaches in some individuals.
Joint Pain: Pain or discomfort in the joints may occur.
Imatib 400 MG Capsule is used in the treatment of several types of cancers. The primary uses of Imatib include:
Chronic Myeloid Leukemia (CML): Imatib is commonly prescribed for the treatment of Chronic Myeloid Leukemia, a type of cancer that affects the blood and bone marrow. It is particularly effective in cases where the cancer cells carry a specific genetic abnormality known as the Philadelphia chromosome.
Acute Lymphoblastic Leukemia (ALL): In certain cases, Imatib may be used in the treatment of Acute Lymphoblastic Leukemia, a fast-growing cancer of the white blood cells.
Gastrointestinal Stromal Tumors (GIST): Imatib is indicated for the treatment of Gastrointestinal Stromal Tumors, which are tumors that occur in the gastrointestinal tract, particularly in the stomach or small intestine. It is effective in targeting specific proteins associated with GIST.
Dermatofibrosarcoma Protuberans (DFSP): Imatib may be prescribed for the treatment of Dermatofibrosarcoma Protuberans, a rare form of skin cancer. It helps in controlling the growth of cancerous cells in the skin.
Here are general guidelines on how to use Imatib:
Dosage and Schedule:
The dosage of Imatib 400 MG Capsule is determined by the healthcare provider based on the specific type of cancer being treated and individual patient factors.
It is crucial to follow the prescribed dosage and administration schedule provided by the healthcare provider.
Administration:
Imatib 400 MG Capsule is usually taken orally with a glass of water.
It can be taken with or without food, but consistency is important. It's advisable to take it at the same time each day.
Adherence to Prescription:
Patients should strictly adhere to the prescribed dosage and administration schedule.
Do not adjust the dosage without consulting with a healthcare professional.
Regular Monitoring:
Regular medical check-ups are essential to monitor the medication's effectiveness and manage potential side effects.
Blood tests and other diagnostic procedures may be performed to assess how well the treatment is working.
Communication with Healthcare Provider:
Patients should maintain open communication with their healthcare provider. Any concerns, changes in health, or experiences of side effects should be promptly reported.
Missed Dose:
If a dose is missed, patients should contact their healthcare provider for guidance on how to proceed. It is not advisable to double up on doses without consulting a healthcare professional.
Precautions:
Patients should inform their healthcare provider about their complete medical history, including any allergies, existing medical conditions, and other medications or supplements being taken.
Side Effects:
Be aware of potential side effects. Common side effects may include nausea, vomiting, fatigue, and muscle cramps. Report any unusual or severe side effects to the healthcare provider.
Pregnancy and Breastfeeding:
If there is a chance of pregnancy or if the patient is breastfeeding, it's crucial to discuss this with the healthcare provider. Imatib may have potential risks during pregnancy.
The information provided on website is intended for educational purposes only and should not be used as a substitute for professional medical advice. Please consult a qualified healthcare professional for personalized medical advice.
with branches throughout the USA
Your information is in safe hands.
on all standard USA orders over $ 250
